Evidence map›Paper›PMID 41098707›Full record

ArticleFrontiers in oncology2025

Evaluation of real-world follow-up methods and their association with adherence and safety in adjuvant breast cancer therapy: a retrospective study.

Na Li, Qian Zhang, Xiaomei Yang, Xiaoli Li, Xixi Tian, Wei Li, Lili Ren, Hua Yang

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Na Li *Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Qian Zhang *Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Xiaomei YangDepartment of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Xiaoli LiDepartment of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Xixi TianTeaching Office, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Wei LiDepartment of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Lili RenDepartment of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
Hua YangDepartment of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To compare the associations between different follow-up management methods-telephone, WeChat, and mini-program-and treatment compliance, safety, quality of life, and self-management in breast cancer patients receiving adjuvant therapy. Methods: This retrospective study reviewed clinical and follow-up records of patients with newly diagnosed breast cancer who underwent adjuvant therapy after radical surgery. Based on documented follow-up modes, patients were categorized into three groups: telephone, WeChat, and the "Doctor Haixin" mini-program. Key clinical indicators, including treatment adherence, quality of life, adverse events, and self-management levels, were extracted from medical records and patient-reported follow-up data collected over a 12-week period. Results: Patients in the mini-program group were found to have higher recorded adherence rates and better self-reported outcomes in quality of life and self-management compared with the telephone and WeChat groups. All groups showed improved quality of life over time, while adverse event rates remained comparable across groups. Conclusion: Among patients retrospectively assessed, those managed via the mini-program follow-up exhibited more favorable patterns in adherence and patient-reported outcomes. These findings suggest that digital platforms may be associated with enhanced care quality in the context of breast cancer follow-up.

Indexed as

breast cancerdigital follow-uppatient-reported outcomesself-managementtreatment compliance

Identifiers

PMID41098707
PMCPMC12518090

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.